Pascal Detampel
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems 3
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 4
- Geriatrics and Gerontology top 10%
-
- RNA Interference and Gene Delivery 9
- Advanced biosensing and bioanalysis techniques 6
- Extracellular vesicles in disease 4
- Protein purification and stability 3
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Virus-based gene therapy research 3
- Co-authors
- Jörg HuwylerAli DehshahriDominik WitzigmannSusanne SchenkElahehnaz ParhizkarStephan KrähenbühlMareike BeckAnutosh Ganguly
- Journals
- Journal of Controlled Release (4 papers)Scientific Reports (3 papers)Journal of Pharmaceutical Sciences (2 papers)
- Partner nations
- SwitzerlandCanadaUnited States
In The Last Decade
Pascal Detampel
34 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Pharmaceutical Science 95
- Biomaterials 170
- Geriatrics and Gerontology 48
- Immunology 176
- Molecular Biology 555
Countries citing papers authored by Pascal Detampel
This map shows the geographic impact of Pascal Detampel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Detampel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Detampel more than expected).
Fields of papers citing papers by Pascal Detampel
This network shows the impact of papers produced by Pascal Detampel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Detampel. The network helps show where Pascal Detampel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pascal Detampel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 8 | |
| 6 | 2023 | 1 | |
| 7 | Polyethylenimine (PEI) in gene therapy: Current status and clinical applicationsbreakdown → | 2023 | 169 |
| 8 | 2023 | 14 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 29 | |
| 11 | 2022 | 17 | |
| 12 | 2020 | 55 | |
| 13 | 2020 | 11 | |
| 14 | 2020 | 13 | |
| 15 | 2019 | 29 | |
| 16 | 2019 | 21 | |
| 17 | 2019 | 43 | |
| 18 | 2017 | 83 | |
| 19 | 2014 | 16 | |
| 20 | 2011 | 10 |
About Pascal Detampel
Pascal Detampel is a scholar working on Structural Biology, Pharmaceutical Science and Biomaterials, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (6 papers), Nanoparticle-Based Drug Delivery (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Extracellular vesicles in disease (4 papers), Virus-based gene therapy research (3 papers), Protein purification and stability (3 papers) and Advanced Drug Delivery Systems (3 papers). The work is most often cited by research in Pharmaceutical Science (95 citations), Biomaterials (170 citations) and Geriatrics and Gerontology (48 citations). Pascal Detampel has collaborated with scholars based in Switzerland, Canada and United States. Frequent co-authors include Jörg Huwyler, Ali Dehshahri, Dominik Witzigmann, Susanne Schenk, Elahehnaz Parhizkar, Stephan Krähenbühl, Mareike Beck, Anutosh Ganguly, Sandro Sieber and Philip Grossen. Their work appears in journals such as Journal of Controlled Release, Scientific Reports, Journal of Pharmaceutical Sciences, European Journal of Pharmaceutics and Biopharmaceutics and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.